NEW YORK, Nov. 17 (GenomeWeb News) - Perlegen Sciences has received a $2.1 million contract from the US National Institute on Drug Abuse to study genetic variations and candidate genes associated with nicotine addiction, the firm said today.
Scientists at WashingtonUniversity in St. Louis will use Perlegen technology to analyze more than 1.5 million SNPs across the genome in people highly addicted to nicotine. They will compare their findings with those conducted on people who are not addicted to nicotine.